Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01004887 · ClinicalTrials.gov registry record

Study of Tissue and Blood Samples From Patients With High-Grade Glioma

A clinical trial of Brain and Central Nervous System Tumors, sponsored by Alliance for Clinical Trials in Oncology.

Completed
Registry status
631
Enrollment target
20
Study locations

NCT01004887 is a study of Brain and Central Nervous System Tumors that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 631 participants, above the 170-participant average among 45 other Brain and Central Nervous System Tumors trials with a reported enrollment target (271% higher). The trial reports 20 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01004887, a study of Brain and Central Nervous System Tumors, has completed, sponsored by Alliance for Clinical Trials in Oncology.

COMPLETED
Registry status
631 participants
Enrollment target
20
Study locations

Study Summary

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at tissue and blood samples from patients with high-grade glioma.

Conditions Studied

Brain and Central Nervous System Tumors

Interventions

  • OTHER diagnostic laboratory biomarker analysis

Study Locations (20)

Illinois

  • Illinois CancerCare - Bloomington - Bloomington
  • St. Joseph Medical Center - Bloomington
  • Graham Hospital - Canton
  • Illinois CancerCare - Canton - Canton
  • Illinois CancerCare - Carthage - Carthage
  • Memorial Hospital - Carthage
  • Eureka Community Hospital - Eureka
  • Illinois CancerCare - Eureka - Eureka
  • Galesburg Clinic, PC - Galesburg
  • Illinois CancerCare - Galesburg - Galesburg
  • Illinois CancerCare - Havana - Havana
  • Mason District Hospital - Havana
  • Illinois CancerCare - Kewanee Clinic - Kewanee
  • Illinois CancerCare - Macomb - Macomb
  • McDonough District Hospital - Macomb
  • Trinity Cancer Center at Trinity Medical Center - 7th Street Campus - Moline

Arizona

  • Mayo Clinic Scottsdale - Scottsdale

Connecticut

  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center - Hartford

Florida

  • Mayo Clinic - Jacksonville - Jacksonville

Idaho

  • Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center - Boise

Trial Details

FieldValue
Enrollment Target 631 participants
Start Date 1995-11
Est. Completion 2019-01-15

Sponsor

Alliance for Clinical Trials in Oncology

446 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01004887

The ClinicalTrials.gov registry entry for NCT01004887 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 631 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 170-participant average among 45 other Brain and Central Nervous System Tumors trials with a reported enrollment target (271% higher). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Brain and Central Nervous System Tumors appearing as the primary indexed condition, and to 1 intervention - of which diagnostic laboratory biomarker analysis is the first listed.

NCT01004887 reports 20 study locations spanning 5 distinct geographic areas - top geographies include Illinois, Arizona, Connecticut.

Frequently Asked Questions

What is clinical trial NCT01004887 about?

NCT01004887 is a clinical study titled "Study of Tissue and Blood Samples From Patients With High-Grade Glioma". RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research st...

What is the current status of trial NCT01004887?

This trial is currently completed. The enrollment target is 631 participants. The study started on 1995-11. Estimated completion is 2019-01-15.

What conditions does trial NCT01004887 study?

This clinical trial studies the following conditions: Brain and Central Nervous System Tumors.

What interventions are being tested in trial NCT01004887?

The interventions under investigation include: diagnostic laboratory biomarker analysis (OTHER).

Who is sponsoring clinical trial NCT01004887?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01004887 being conducted?

This trial has 20 study locations across Arizona, Connecticut, Florida, Idaho, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Brain and Central Nervous System Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Brain and Central Nervous System Tumors

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.